logo-loader
Benchmark Holdings PLC

Benchmark Holdings appoints Dechra Pharmaceutical director as CFO

Septima Maguire, who spent four years at Dechra Pharmaceuticals, will start her new role at Benchmark in November

Benchmark Holdings PLC -
Benchmark is an aquaculture health, advanced nutrition, and genetics business

Benchmark Holdings PLC (LON:BMK) has appointed the corporate development director of veterinary pharmaceuticals firm Dechra Pharmaceutical PLC (LON:DPH) as its chief financial officer.

Septima Maguire will start her new role at Benchmark in November, replacing Mark Plampin, who will remain at the aquaculture health business until January to ensure a smoothe transition.

Maguire held a number of senior roles at Dechra during her four years at the company. She joined the group as financial controller and was acting finance director between 2016 and 2017.

In her most recent role as corporate development director, she was responsible for overseeing acquisition activities, strategic projects, business development and investment initiatives.

She has also held finance roles at packaging manufacturer Ardagh Group S.A., Impress Global, CHN Capital and PricewaterhouseCoopers.

"We are delighted to have recruited someone of Septima's calibre. She has extensive strategic, investor and operational finance experience and proven expertise in driving improved business performance,” said Benchmark chief executive Malcolm Pye.

“She will be a valuable member of the leadership team as we focus on implementing structural and operational efficiencies and delivering on our five year strategy to drive future growth and profitability."

Quick facts: Benchmark Holdings PLC

Price: £0.40

Market: AIM
Market Cap: £225.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Benchmark Holdings PLC named herein, including the promotion by the Company of Benchmark Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Benchmark Holdings identifies breakthrough to help Tilapia fight disease

Top stories from the Proactive Investors UK newsroom. Aquaculture specialist Benchmark (LON:BMK) has claimed a breakthrough that might increase genetic resistance to a major infection in tilapia. The company has identified a strain of DNA that can help the fish fight off the disease more...

on 11/7/19

RNS

Directorate Change

3 days, 8 hours ago

Details of Investor Call

5 days, 23 hours ago

Directorate Change

1 week, 1 day ago

Q3 Trading Update

1 week, 3 days ago

Total Voting Rights

3 weeks, 1 day ago

Directorate Change

on 9/7/19

2 min read